As shown in the Figure S2, the combinatorial treatment strongly inhibited the phosphorylation of ERK, thus confirming that this combined treatment acts by inhibiting cell proliferation in line with previous reports indicating that inhibition of EGFR and ICs counteracts tumor cell growth [33,35,42]. The gene discussed is EGFR; the disease is neoplasm.